|Product name||Recombinant Human BAFFR Protein|
|Description||Recombinant Human Siglec-2/CD22 Protein is produced by mammalian expression system. The target protein is expressed with sequence (Ser7-Ala71) of human BAFFR (Accession #Q96RJ3-1) fused with a 6xHis tag at the C-terminus.|
|Bio-Activity||Immobilized Human BAFFR, His Tag at 1ug/mL (100μL/well), dose response curve for Human BAFF with the EC50 of 0.15ug/mL determined by ELISA. Immobilized Human BAFFR, His Tag at 0.5ug/mL (100μL/well), dose response curve for Human BAFFR Ab with the EC50 of 5.1ng/mL determined by ELISA.|
|Purity||> 95% by SDS-PAGE.|
|Endotoxin||< 0.1 EU/μg of the protein by LAL method.|
|Formulation||Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation.|
|Synonym||BAFF-R; BAFFR; BROMIX; CD268; CVID4; prolixin|
|Storage||Store the lyophilized protein at -20°C to -80 °C for long term.|
After reconstitution, the protein solution is stable at -20 °C for 3 months, at 2-8 °C for up to 1 week.
|Reconstitution||Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water.|
* For research use only. Not for therapeutic or diagnostic purposes.
Submit your question about RP02004 below and we will get back to you within one business day.
Alternatively, call us at 888.754.5670.